Evidence map›Paper›PMID 40537834›Full record

Trial reportCritical care (London, England)2025

What is the optimal approach to analyse ventilator-free days? A simulation study.

Laurent Renard Triché, Matthieu Jabaudon, Nicolas Molinari, Jean-Marie Forel, Jean-Michel Constantin, Bruno Pereira, Sylvie Chevret

4 registry-linked trialsAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Critical care (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00000579 phase3completednot on this map

Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)

TypeinterventionalSponsorNational Heart, Lung, and Blood Institute (NHLBI)Ran1994 to 2004ConditionsRespiratory Distress Syndrome, Adult, Lung DiseasesArmsLow Tidal Volume Ventilation, Positive End-Expiratory Pressure, Lysofylline, Methylprednisolone, Ketoconazole
NCT00299650 phase4completednot on this map

Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients

TypeinterventionalSponsorAssistance Publique Hopitaux De MarseilleRan2006 to 2008Enrolled340ConditionsARDSArmscisatracurium, Placebo, Cisatracurium besilate
NCT02149589 nacompletednot on this map

Lung Imaging for Ventilatory Setting in ARDS

TypeinterventionalSponsorUniversity Hospital, Clermont-FerrandRan2014 to 2018Enrolled420ConditionsARDSArmsMechanical ventilation
NCT04344730 naunknown statusnot on this map

Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 pneumonia_COVIDICUS

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2020 to 2021Enrolled550ConditionsAcute Hypoxemic Respiratory Failure, COVID-19ArmsDexamethasone injection, placebo, conventional oxygen, CPAP, HFNO
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Higher (40%) versus lower (30%) FiOEuropean journal of pediatrics · 2025
    Trial
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laurent Renard TrichéDepartment of Perioperative Medicine, CHU Clermont-Ferrand, 58 rue Montalembert, 63 003, Clermont-Ferrand, France. lrenard--triche@chu-clermontferrand.fr.ORCID http://orcid.org/0000-0002-3971-9093
Matthieu JabaudonDepartment of Perioperative Medicine, CHU Clermont-Ferrand, 58 rue Montalembert, 63 003, Clermont-Ferrand, France.ORCID http://orcid.org/0000-0002-8121-1680
Nicolas MolinariIDESP, INSERM, PreMEdical INRIA, Univ Montpellier, CHU Montpellier, Montpellier, France.ORCID http://orcid.org/0000-0002-1786-0088
Jean-Marie ForelMédecine Intensive et Réanimation, Hôpital Nord, Assistance Publique - Hôpitaux de Marseille, Marseille, France.ORCID http://orcid.org/0000-0002-1958-7388
Jean-Michel ConstantinSorbonne University, GRC 29, AP-HP, DMU DREAM, Department of Anesthesiology and Critical Care, Pitié-Salpêtrière Hospital, Paris, France.ORCID http://orcid.org/0000-0001-7634-5898
Bruno PereiraBiostatistics Unit, Department of Clinical Research, and Innovation (DRCI), CHU Clermont-Ferrand, Clermont-Ferrand, France.ORCID http://orcid.org/0000-0003-3778-7161
Sylvie ChevretECSTRRA Team, IRSL, INSERM UMR1342, Université Paris Cité, Paris, France.ORCID http://orcid.org/0000-0001-6449-4730

Funding

Programme Hospitalier de Recherche Clinique InterRégional 2013
6 · The paper itself

Abstract

backgroundVentilator-free days (VFDs) are a composite outcome in critical care research, reflecting both survival and mechanical ventilation duration. However, analysis methods for VFDs are inconsistent, with some focusing on counts and others on time-to-event outcomes, while other approaches such as the multistate model and the win ratio have emerged. We aimed to evaluate various statistical models through simulations to identify the optimal approach for analysing VFDs.

methodsFirst, 16 datasets of 300 individuals were simulated, comparing a control group to an intervention with varying survival rates and ventilation durations. Various statistical models were evaluated for statistical power and Type I error rate. Four clinical trial datasets (LIVE study, NCT02149589; ARMA study, NCT00000579; ACURASYS study, NCT00299650; COVIDICUS study, NCT04344730) were then used to apply the same statistical models to analyse VFDs. Twelve statistical methods were evaluated, including count-based, time-to-event approaches, and the win-ratio. Additionally, sensitivity analyses were conducted.

resultsMost statistical methods effectively controlled Type I error rate, except for the zero-inflated and hurdle Poisson/negative binomial count submodels, as well as the cause-specific Cox regression model for death. The power to detect survival benefit and ventilation duration effects varied, with time-to-event approaches, the Mann-Whitney test, the proportional odds model and the win ratio generally performing best. Similar results were observed in sensitivity analyses. In the real datasets, the multistate model, the Mann-Whitney test, the proportional odds model and the win ratio generally showed a significant association between VFDs and randomisation groups.

conclusionsThe multistate model could be recommended as the optimal approach for analysing VFDs, as it outperformed the other methods and offers a more interpretable effect size than the proportional odds model and the win ratio.

Indexed as

Respiration, ArtificialComputer SimulationHumansModels, StatisticalTime FactorsComputer simulationModels, statisticalRespiratory distress syndromeSoftwareSurvival analysis

Identifiers

PMID40537834
PMCPMC12180158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.